Consistent with baseline differences in cell growth, Keap1 expressing clones showed poorer tumorsphere formation after cisplatin treatment with clear contrast in parental and control cells (Fig. 4J), suggesting additional evidence of therapeutic resistance in HNSCC through self-renewal of the tumor cells. Here, KEAP1 is linked to head and neck squamous cell carcinoma.